ADRM1 Antibodies

Santa Cruz Biotechnology delivers a wide array of ADRM1 monoclonal antibodies for research focused on understanding ADRM1 protein functions. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADRM1, also known as the ADP-ribosylation factor-like protein 1, plays a crucial role in cellular processes such as protein degradation and proteasome regulation. ADRM1 actively participates in cellular stress response and maintains protein homeostasis, making it significant in cancer and neurodegenerative disease research. Studying ADRM1 can reveal potential therapeutic targets and enhance understanding of disease progression mechanisms. Researchers worldwide rely on ADRM1 monoclonal antibodies to advance their investigations in protein degradation pathways. Current research utilizing ADRM1 monoclonal antibodies has expanded knowledge in proteasome regulation and cellular stress responses. ADRM1 monoclonal antibodies from Santa Cruz Biotechnology enable scientists to make meaningful contributions to understanding disease mechanisms and developing therapeutic strategies.